CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 61,600 shares (grant or award)
- 4 Grant or award Director acquired 62,800 shares (grant or award)
- 4 Grant or award Director acquired 18,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,780,874 shares (grant or award)
- 4 Grant or award Director acquired 62,800 shares (grant or award)
- 4 Grant or award Director acquired 61,600 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 120,900 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 1 of 8 · 146 filings